KIT-mutated pediatric core-binding factor systemic mastocytosis-acute myeloid leukemia treated with avapritinib and decitabine

Pediatr Blood Cancer. 2024 Apr;71(4):e30898. doi: 10.1002/pbc.30898. Epub 2024 Jan 30.

Affiliations

¹ Department of Pediatrics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
² Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
³ Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.

PMID: 38291730
DOI: 10.1002/pbc.30898

No abstract available

Publication types

Letter

MeSH terms

Child
Core Binding Factors
Decitabine
Humans
Leukemia, Myeloid, Acute* / drug therapy
Leukemia, Myeloid, Acute* / genetics
Mastocytosis, Systemic*
Mutation
Proto-Oncogene Proteins c-kit / genetics
Pyrazoles*
Pyrroles*
Triazines*

Substances

avapritinib
Decitabine
Core Binding Factors
Proto-Oncogene Proteins c-kit
Pyrazoles
Pyrroles
Triazines